Abstract
Chronic lower extremity arterial occlusive disease and carotid artery stenosis are common problems faced by most vascular surgeons. Due to technological advancements in stent technology, lower profile delivery systems, and the dexterity of vascular interventionalists, endovascular therapy of the femoropopliteal and cerebrovascular systems has gained wide acceptance. However, in-stent restenosis continues to limit the longevity of percutaneous vascular interventions. This chapter examines the management of patients with in-stent restenosis after femoropopliteal and carotid artery angioplasty and stenting.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tetteroo E, van der Graaf Y, Bosch JL, et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac stent Trial Study Group. Lancet. 1998;351(9110):1153–9.
Murphy TP, Hirsch AT, Ricotta JJ, et al. The Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) study. J Vasc Surg. 2008;47(6):1356–63.
Dormandy JA, Rutherford RB. Management of peripheral arterial disease. TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:S1–296.
Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(suppl):S5–67.
Adam DJ, Beard JD, Cleveland T, et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg: multicenter, randomized controlled trial. Lancet. 2005;366:1925–36.
Krakenberg H, Schluter M, Steinkamp HJ, et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial(FAST). Circulation. 2007;116(3):285–92.
Davies MG, Bismuth J, Saad WE, et al. Outcomes of reintervention for recurrent disease after percutaneous iliac angioplasty and stenting. J Endovasc Ther. 2011;18:169–80.
Schillinger M, Sabeti S, Loewe C, et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006;354(18):1879–88.
Minare E, Schillinger M. New stents for SFA. J Cardiovasc Surg. 2009;50(5):635–45.
Tosaka A, Yoshimitsu S, Osamu I, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol. 2012;59(1):16–23.
Schmidt A, Bausback Y, Piorkowski M, et al. Retrograde recanalization technique for use after failed antegrade angioplasty in chronic femoral artery occlusions. J Endovasc Ther. 2012;19(1):23–9.
Gandini R, Del Giudice C, Ondo EP, et al. Stent puncture for recanalization of occluded superficial femoral artery stents. J Endovasc Ther. 2012;19(1):30–3.
Brott TG, Halperin JL, Abbara S, et al. 2011 SA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. J Am Coll Cardiol. 2011;57(8):1002–44.
Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics – 2010 update: a report from the American Heart Association. Circulation. 2010;121(7):948–54.
Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351(15):1493–501.
Gray WA, Hopkins LN, Yadav S, et al. ARCHeR Trial Collaborators: protected carotid stenting in high-surgical-risk patients- the ARCHeR results. J Vasc Surg. 2006;44(2):258–68.
Kasirajan K. Technique of carotid bifurcation angioplasty and stent placement: how I do it. In: Schneider PA, Bohannon WT, Silva MB, editors. Carotid interventions. New York: Marcel Dekker; 2004. p. 149–64.
Kasirajan K, Schneider P. Carotid bifurcation stented balloon angioplasty with cerebral protection. In: Moore WS, Ahn SS, editors. Endovascular surgery. Philadelphia: Elsevier/Saunders; 2011. p. 405–19.
Naylor AR, Bolia A, Abbott RJ, et al. Randomized study of carotid angioplasty and stenting versus carotid endarterectomy: a stopped trial. J Vasc Surg. 1998;28(2):326–34.
Ricotta 2nd JJ, Malgor RD. A review of the trials comparing carotid endarterectomy and carotid angioplasty and stenting. Perspect Vasc Surg Endovasc Ther. 2008;20(3):299–308.
Brott TG, Hobson 2nd RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med. 2010;363(1):11–23.
Mas JL, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med. 2006;355(16):1660–71.
Ringleb PA, Allenberg J, Bruckmann H. 30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet. 2006;368(9543):1239–47.
Lal BK, Brott TG. The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results. J Vasc Surg. 2009;50(5):1224–31.
CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet. 2001;357(9270):1729–37.
Bonati LH, Ederle J, Dominick JH, et al. Long term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long term follow-up of a randomized trial. Lancet. 2009;8(10):908–17.
Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and angioplasty with protection in patients at high risk for endarterectomy. SAPPHIRE. N Engl J Med. 2004;351(15):1493–501.
Peterson BG, Longo GM, Kibbe MR, et al. Duplex ultrasound remains a reliable test even after carotid stenting. Ann Vasc Surg. 2005;19(6):793–7.
Lal BK, Hobson RW, Tofighi B, et al. Duplex ultrasound velocity criteria for the stented carotid artery. J Vasc Surg. 2008;47:63–73.
Harrer JU, Morschel R, Mull M, et al. High rate of restenosis after carotid artery stenting in patients with high-grade internal carotid artery stenosis. J Neurol. 2008;255:1309–14.
Zhou W, Lin PH, Bush RL, et al. Management of in-stent restenosis after carotid artery stenting in high-risk patients. J Vasc Surg. 2006;43:305–12.
Groschel K, Riecker A, Schulz JB, et al. Systematic Review of early recurrent stenosis after carotid angioplasty and stenting. Stroke. 2005;36:367–73.
Chakhtoura EY, Hobson RW, Goldstein J, et al. In-stent restenosis after carotid angioplasty-stenting: incidence and management. J Vasc Surg. 2001;33:220–6.
Brown KR, Desai TR, Schwartz LB, et al. Operative intervention for recurrent stenosis after carotid stent angioplasty: a report. Ann Vasc Surg. 2002;16:575–8.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Lee, M., Kibbe, M.R. (2014). Endovascular Treatment of Restenotic Lesions. In: Dieter, R., Dieter, Jr., R., Dieter, III, R. (eds) Endovascular Interventions. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7312-1_9
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7312-1_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7311-4
Online ISBN: 978-1-4614-7312-1
eBook Packages: MedicineMedicine (R0)